Robert Copeland-Halperin

410 total citations
7 papers, 270 citations indexed

About

Robert Copeland-Halperin is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Copeland-Halperin has authored 7 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Copeland-Halperin's work include Diabetic Foot Ulcer Assessment and Management (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Coronary Interventions and Diagnostics (1 paper). Robert Copeland-Halperin is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Coronary Interventions and Diagnostics (1 paper). Robert Copeland-Halperin collaborates with scholars based in United States and Spain. Robert Copeland-Halperin's co-authors include Benjamin J. Hirsh, Jonathan L. Halperin, Valentı́n Fuster, José M. Castellano, Prakash Krishnan, Melissa Aquino, Roxana Mehran, George Dangas, Anitha Rajamanickam and Pedro Moreno and has published in prestigious journals such as Journal of the American College of Cardiology, Arteriosclerosis Thrombosis and Vascular Biology and The Oncologist.

In The Last Decade

Robert Copeland-Halperin

5 papers receiving 264 citations

Peers

Countries citing papers authored by Robert Copeland-Halperin

Since Specialization

Citations

This map shows the geographic impact of Robert Copeland-Halperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Copeland-Halperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Copeland-Halperin more than expected).

Fields of papers citing papers by Robert Copeland-Halperin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Copeland-Halperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Copeland-Halperin. The network helps show where Robert Copeland-Halperin may publish in the future.

Co-authorship network of co-authors of Robert Copeland-Halperin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Copeland-Halperin. A scholar is included among the top collaborators of Robert Copeland-Halperin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Copeland-Halperin. Robert Copeland-Halperin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Non-bacterial Thrombotic Endocarditis in Lung Cancer: A Systematic Review 2025 ·Current Cardiology Reviews ·(unknown), Fahad Hussain, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Robert Copeland-Halperin, Nagashree Seetharamu	0
2	INCIDENCE OF BRUTON TYROSINE KINASE INHIBITOR ASSOCIATED ARRHYTHMIAS: A PROSPECTIVE ANALYSIS USING CONTINUOUS INSERTABLE CARDIAC MONITORS 2025 ·Journal of the American College of Cardiology ·Jason Ng, (unknown), (unknown), (unknown), (unknown), Joanna Rhodes, Haisam Ismail, Robert Copeland-Halperin	0
3	Considerations for the practical management of cardiovascular risk with Bruton’s tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia 2025 ·The Oncologist ·Daniel J. Lenihan, Michelle Bloom, Robert Copeland-Halperin, Matthew R. Fleming, Michael G. Fradley, Rupal O’Quinn, Seema A. Bhat	2
4	Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer‐generation DES: Findings from a large multiethnic registry 2017 ·Catheterization and Cardiovascular Interventions ·Robert Copeland-Halperin, Usman Baber, Melissa Aquino, Anitha Rajamanickam, (unknown), (unknown), Nitin Barman, Jason C. Kovacic, Pedro Moreno, Prakash Krishnan, Joseph Sweeny, Roxana Mehran, George Dangas, Annapoorna Kini, Samin K. Sharma	73
5	Fibrotic Atrial Cardiomyopathy, Atrial Fibrillation, and Thromboembolism 2015 ·Journal of the American College of Cardiology ·Benjamin J. Hirsh, Robert Copeland-Halperin, Jonathan L. Halperin	148
6	Aiming at Strategies for a Complex Problem of Medical Nonadherence 2013 ·Global Heart ·José M. Castellano, Robert Copeland-Halperin, Valentı́n Fuster	26
7	Impaired Skeletal Muscle Glucose Uptake by [ ¹⁸ F]Fluorodeoxyglucose–Positron Emission Tomography in Patients With Peripheral Artery Disease and Intermittent Claudication 2010 ·Arteriosclerosis Thrombosis and Vascular Biology ·Reena L. Pande, Mi‐Ae Park, Todd S. Perlstein, Akshay S. Desai, (unknown), (unknown), Robert Copeland-Halperin, (unknown), Marcelo F. Di Carli, Mark A. Creager	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact